• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼底控制视野计(微视野计):在临床试验中的应用作为结局指标。

Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials.

机构信息

Department of Ophthalmology, University of Bonn, Bonn, Germany; Department of Biomedical Data Science, Stanford University, Stanford, USA.

Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

出版信息

Prog Retin Eye Res. 2021 May;82:100907. doi: 10.1016/j.preteyeres.2020.100907. Epub 2020 Oct 3.

DOI:10.1016/j.preteyeres.2020.100907
PMID:33022378
Abstract

Fundus-controlled perimetry (FCP, also called 'microperimetry') allows for spatially-resolved mapping of visual sensitivity and measurement of fixation stability, both in clinical practice as well as research. The accurate spatial characterization of visual function enabled by FCP can provide insightful information about disease severity and progression not reflected by best-corrected visual acuity in a large range of disorders. This is especially important for monitoring of retinal diseases that initially spare the central retina in earlier disease stages. Improved intra- and inter-session retest-variability through fundus-tracking and precise point-wise follow-up examinations even in patients with unstable fixation represent key advantages of these technique. The design of disease-specific test patterns and protocols reduces the burden of extensive and time-consuming FCP testing, permitting a more meaningful and focused application. Recent developments also allow for photoreceptor-specific testing through implementation of dark-adapted chromatic and photopic testing. A detailed understanding of the variety of available devices and test settings is a key prerequisite for the design and optimization of FCP protocols in future natural history studies and clinical trials. Accordingly, this review describes the theoretical and technical background of FCP, its prior application in clinical and research settings, data that qualify the application of FCP as an outcome measure in clinical trials as well as ongoing and future developments.

摘要

眼底控制视野计(FCP,也称为“微视野计”)允许对视觉灵敏度进行空间分辨映射,并测量注视稳定性,无论是在临床实践中还是在研究中。FCP 实现的视觉功能的精确空间特征可以提供有关疾病严重程度和进展的有见地的信息,而这些信息在很大程度上不能通过最佳矫正视力反映出来。对于监测在早期疾病阶段最初保留中心视网膜的视网膜疾病,这一点尤为重要。通过眼底跟踪和精确的点式随访检查,可以提高内和间测试变异性,即使在固定不稳定的患者中也能如此,这是这些技术的关键优势。特定疾病的测试模式和协议的设计可以减少广泛而耗时的 FCP 测试的负担,从而使测试更有意义和更有针对性。最近的发展还允许通过实施暗适应色觉和明适应测试来进行光感受器特异性测试。详细了解各种可用设备和测试设置是未来自然史研究和临床试验中设计和优化 FCP 协议的关键前提。因此,本综述描述了 FCP 的理论和技术背景、其在临床和研究环境中的先前应用、将 FCP 作为临床试验中结果测量的应用的合格数据以及正在进行和未来的发展。

相似文献

1
Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials.眼底控制视野计(微视野计):在临床试验中的应用作为结局指标。
Prog Retin Eye Res. 2021 May;82:100907. doi: 10.1016/j.preteyeres.2020.100907. Epub 2020 Oct 3.
2
Visual field indices and patterns of visual field deficits in mesopic and dark-adapted two-colour fundus-controlled perimetry in macular diseases.在黄斑疾病的中间光和暗适应双色眼底控制视野检查中,视野指数和视野缺损模式。
Br J Ophthalmol. 2018 Aug;102(8):1054-1059. doi: 10.1136/bjophthalmol-2017-311012. Epub 2017 Nov 16.
3
Inferred retinal sensitivity in recessive Stargardt disease using machine learning.使用机器学习推断隐性斯塔加特病的视网膜敏感性。
Sci Rep. 2021 Jan 14;11(1):1466. doi: 10.1038/s41598-020-80766-4.
4
Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration.基于形态学的人工智能在新生血管性年龄相关性黄斑变性中的功能预测。
Sci Rep. 2019 Jul 31;9(1):11132. doi: 10.1038/s41598-019-47565-y.
5
[Fundus-controlled microperimetry with the scanning laser ophthalmoscope in macular diseases].[使用扫描激光检眼镜进行眼底控制的微视野检查在黄斑疾病中的应用]
Klin Monbl Augenheilkd. 1993 Sep;203(3):212-8. doi: 10.1055/s-2008-1045670.
6
Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.在斯塔加特病萎缩进展期斯塔加特病(ProgStar)研究中使用微视野计测量黄斑敏感性:第7号报告。
JAMA Ophthalmol. 2017 Jul 1;135(7):696-703. doi: 10.1001/jamaophthalmol.2017.1162.
7
Effective Dynamic Range and Retest Reliability of Dark-Adapted Two-Color Fundus-Controlled Perimetry in Patients With Macular Diseases.黄斑疾病患者暗适应双色眼底控制视野检查的有效动态范围和重测可靠性
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO158-BIO167. doi: 10.1167/iovs.17-21454.
8
Retinal light sensitivity as outcome measure in recessive Stargardt disease.视网膜光敏感度作为隐性斯塔加特病的结局测量指标。
Br J Ophthalmol. 2021 Feb;105(2):258-264. doi: 10.1136/bjophthalmol-2020-316201. Epub 2020 Apr 28.
9
Mesopic and dark-adapted two-color fundus-controlled perimetry in patients with cuticular, reticular, and soft drusen.皮肤样、网状和软性玻璃膜疣患者的明适应和暗适应双色眼底周边视野检查。
Eye (Lond). 2018 Dec;32(12):1819-1830. doi: 10.1038/s41433-018-0183-3. Epub 2018 Aug 1.
10
Macular function in macular degenerations: repeatability of microperimetry as a potential outcome measure for ABCA4-associated retinopathy trials.黄斑变性中的黄斑功能:微视野计的重复性作为 ABCA4 相关性视网膜病变试验的潜在结果测量指标。
Invest Ophthalmol Vis Sci. 2012 Feb 21;53(2):841-52. doi: 10.1167/iovs.11-8415. Print 2012 Feb.

引用本文的文献

1
Macular function measured by Nidek MP-3 microperimeter in normal Chinese individuals across age groups.采用尼德克MP-3微视野计测量不同年龄组正常中国人的黄斑功能。
PeerJ. 2025 Sep 9;13:e19961. doi: 10.7717/peerj.19961. eCollection 2025.
2
Targeted Defect-Mapping Microperimetry in Geographic Atrophy: A Sensitive Functional Outcome Measure for Intervention Trials.地图样萎缩中的靶向缺陷映射微视野检查:干预试验的一种敏感功能结局指标
Ophthalmol Sci. 2025 Jun 14;5(6):100856. doi: 10.1016/j.xops.2025.100856. eCollection 2025 Nov-Dec.
3
Visual field defects in dementia: A scoping review.
痴呆症中的视野缺损:一项范围综述。
Ophthalmic Physiol Opt. 2025 Sep;45(6):1359-1375. doi: 10.1111/opo.13550. Epub 2025 Jul 26.
4
An Analysis of Scotopic Microperimetry in Healthy Adults.健康成年人的暗视微视野检查分析
Transl Vis Sci Technol. 2025 Jun 2;14(6):18. doi: 10.1167/tvst.14.6.18.
5
Onset of End-Stage Atrophic Age-Related Macular Degeneration as an End Point-A Delphi Study: Classification of Atrophy Meetings Report 7.以晚期萎缩性年龄相关性黄斑变性的发病为终点——德尔菲研究:萎缩会议报告7分类
Ophthalmol Sci. 2025 Mar 28;5(5):100777. doi: 10.1016/j.xops.2025.100777. eCollection 2025 Sep-Oct.
6
Geographic atrophy: Understanding the relationship between structure and function.地图样萎缩:理解结构与功能之间的关系。
Asia Pac J Ophthalmol (Phila). 2025 May-Jun;14(3):100207. doi: 10.1016/j.apjo.2025.100207. Epub 2025 May 19.
7
Progression of Atrophy as a Function of ABCA4 Variants and Age of Onset in Stargardt Disease.萎缩进展与Stargardt病中ABCA4变体及发病年龄的关系
Invest Ophthalmol Vis Sci. 2025 Apr 1;66(4):76. doi: 10.1167/iovs.66.4.76.
8
Comparison Between MAIA and MP-3 In Healthy Subjects and Patients With Diabetes, Diabetic Retinopathy, and Age-Related Macular Degeneration.MAIA与MP-3在健康受试者以及糖尿病、糖尿病视网膜病变和年龄相关性黄斑变性患者中的比较。
Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):59. doi: 10.1167/iovs.66.3.59.
9
Rethinking Clinical Trials in Age-Related Macular Degeneration: How AI-Based OCT Analysis Can Support Successful Outcomes.重新思考年龄相关性黄斑变性的临床试验:基于人工智能的光学相干断层扫描分析如何助力取得成功结果。
Pharmaceuticals (Basel). 2025 Feb 20;18(3):284. doi: 10.3390/ph18030284.
10
Charles Bonnet Syndrome associated with unilateral vision loss: A new diagnostic perspective.与单眼视力丧失相关的查尔斯·博内综合征:一种新的诊断视角。
Ophthalmic Physiol Opt. 2025 May;45(3):681-688. doi: 10.1111/opo.13481. Epub 2025 Mar 18.